Tech Company Financing Transactions
QCDx Funding Round
On 5/1/2025, QCDx raised $7 million in financing from private investors.
Transaction Overview
Company Name
Announced On
5/1/2025
Transaction Type
Venture Equity
Amount
$7,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The proceeds from this financing will enable the achievement of several key milestones including launch of: a new diagnostic instrument; a breast cancer monitoring assay; proprietary multiplex immunofluorescence reagent kits; and a CLIA -certified clinical laboratory.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
400 Farmington Avenue, R1826
Farmington, CT 06032
USA
Farmington, CT 06032
USA
Phone
Website
Email Address
Overview
QCDx is a medical company dedicated to providing solutions for detecting and profiling rare cells in the blood circulation. Our mission is to reveal circulating cancer cell heterogeneity both In early stage and advanced disease to deliver precision cancer diagnosis that will enable the oncologist to optimize treatment, monitor therapy, characterize metastasis and assess treatment toxicity. Ultimately, to improve patient outcomes and their quality of life
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Triantafyllos Tafas
Chief Financial Officer
Patrick Curry
Chief Information Officer
Brian Ciarcia
Chief Scientific Officer
Seth Winfree
Browse more venture capital transactions:
Prev: 5/1/2025: Supio venture capital transaction
Next: 5/1/2025: The Networking People venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs